<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39412952</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2369-2960</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>16</Day></PubDate></JournalIssue><Title>JMIR public health and surveillance</Title><ISOAbbreviation>JMIR Public Health Surveill</ISOAbbreviation></Journal><ArticleTitle>Protective Effect of Allergen Immunotherapy in Patients With Allergic Rhinitis and Asthma Against COVID-19 Infection: Observational, Nationwide, and Multicenter Study.</ArticleTitle><Pagination><StartPage>e50846</StartPage><MedlinePgn>e50846</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e50846</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/50846</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Allergic diseases are associated with an increased susceptibility to respiratory tract infections. Although allergen immunotherapy (AIT) alters the course of allergies, there is limited evidence from clinical practice demonstrating its ability to enhance the host defense against pathogens.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">The aim of this study was to investigate the protective effect of AIT against viral infection in patients with allergic rhinitis (AR) and allergic asthma (AS) based on clinical evidence.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A multicenter, questionnaire-based survey was conducted during a tremendous surge in COVID-19 cases between February 10, 2023, and March 15, 2023, in 81 centers across China recruiting healthy volunteers and patients with AR and AS to investigate the clinical outcomes of COVID-19 infection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of 10,151 participants recruited in the survey, 3654 patients and 2192 healthy volunteers who tested positive for COVID-19 were included in this analysis after screening. Overall, no significant differences in COVID-19 outcomes were observed between patients and healthy volunteers. An additional 451 patients were excluded due to their use of biologics as the sole add-on treatment, leaving 3203 patients in the further analysis. Of them, 1752 were undergoing routine medication treatment (RMT; the RMT group), whereas 1057 and 394 were receiving AIT and a combination of AIT and omalizumab (OMA) as adjunct therapies to RMT, respectively (AIT+RMT and AIT+OMA+RMT groups). The AIT group showed milder COVID-19 symptoms, shorter recovery periods, and a lower likelihood of hospitalization or emergency department visits than the RMT group (all P&lt;.05). After adjusting for confounding factors, including demographic characteristics and COVID-19 vaccination, AIT remained a significant protective factor associated with shorter recovery time (adjusted odds ratio [OR] 0.62, 95% CI 0.52-0.75; adjusted P&lt;.001) and a lower incidence of hospitalization or emergency department visits (adjusted OR 0.73, 95% CI 0.54-0.98; adjusted P=.03). Furthermore, the AIT+OMA+RMT group showed greater protection with a shorter recovery time (adjusted OR 0.51, 95% CI 0.34-0.74; adjusted P&lt;.001) than the AIT+RMT group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Our multicenter observational study provides valuable clinical evidence supporting the protective effect of AIT against COVID-19 infection in patients with AR and AS.</AbstractText><CopyrightInformation>© Rundong Qin, Yan Feng, Huanping Zhang, Beibei Zhao, Wei Lei, Hongying Sun, Lili Zhi, Zhongsheng Zheng, Siqin Wang, Yafeng Yu, Shengxue Jiang, Changshan Liu, Xingkai Ma, Hui Ma, Huiying Wang, Hang Lin, Qiaojie He, Lingying Wu, Yingying Zhai, Honglue Lu, Shi Chen, Yan Ma, Xiaohong Jin, Shan Deng, Nanshan Zhong, Ruchong Chen, Jing Li. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Rundong</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8067-6307</Identifier><AffiliationInfo><Affiliation>Department of Allergy and Clinical Immunology, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China, 86 189 2886 8259, 86 20 3429 8996.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-1443-0584</Identifier><AffiliationInfo><Affiliation>Department of Otolaryngology Head and Neck Surgery, The First Hospital, Shanxi Medical University, Taiyuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Huanping</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-2263-6774</Identifier><AffiliationInfo><Affiliation>Department of Allergology, Shanxi Bethune Hospital, Shanxi Academy of Medical Science, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Shanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Beibei</ForeName><Initials>B</Initials><Identifier Source="ORCID">0009-0000-1797-9831</Identifier><AffiliationInfo><Affiliation>Department of Allergy, The Second Affiliated Hospital of Dalian Medical University, Liaoning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Wei</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0001-8498-7161</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Hongying</ForeName><Initials>H</Initials><Identifier Source="ORCID">0009-0006-7707-6451</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhi</LastName><ForeName>Lili</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-5664-9974</Identifier><AffiliationInfo><Affiliation>Department of Allergy, Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Zhongsheng</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-2587-7680</Identifier><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Siqin</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3601-7827</Identifier><AffiliationInfo><Affiliation>Department of Allergy, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yafeng</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-3558-0263</Identifier><AffiliationInfo><Affiliation>Department of Otolaryngology, The First Affiliated Hospital of Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Shengxue</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0007-4803-6415</Identifier><AffiliationInfo><Affiliation>Department of Allergy, Shengjing Hospital of China Medical University, Liaoning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Changshan</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-1828-8204</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, The Second Hospital of Tianjin Medical University, Children's Respiratory and Asthma Research Center of Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Xingkai</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-5337-8977</Identifier><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, The Affiliated Zhangjiagang Hospital of Soochow University, Zhangjiagang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Hui</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-4854-6187</Identifier><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Chest Hospital, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Huiying</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-4855-4323</Identifier><AffiliationInfo><Affiliation>Department of Allergy and Clinical Immunology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Hang</ForeName><Initials>H</Initials><Identifier Source="ORCID">0009-0005-3122-6779</Identifier><AffiliationInfo><Affiliation>Department of Allergy, The Affiliated Hospital of Qingdao University, Qingdao, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Qiaojie</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0009-0007-8060-9404</Identifier><AffiliationInfo><Affiliation>Department of Allergy, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Lingying</ForeName><Initials>L</Initials><Identifier Source="ORCID">0009-0005-2357-9785</Identifier><AffiliationInfo><Affiliation>Department of Allergy, The Third People's Hospital of Datong, Datong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhai</LastName><ForeName>Yingying</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-9668-562X</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Honglue</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-0882-2311</Identifier><AffiliationInfo><Affiliation>Department of Otolaryngology, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shi</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0008-5061-0364</Identifier><AffiliationInfo><Affiliation>Center for Prevention and Treatment of Pediatric Asthma, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-7684-7254</Identifier><AffiliationInfo><Affiliation>Department of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Xiaohong</ForeName><Initials>X</Initials><Identifier Source="ORCID">0009-0003-9918-446X</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Shan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9645-5397</Identifier><AffiliationInfo><Affiliation>Department of Allergy, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Nanshan</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-2274-1427</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ruchong</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5376-8230</Identifier><AffiliationInfo><Affiliation>Department of Allergy and Clinical Immunology, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China, 86 189 2886 8259, 86 20 3429 8996.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jing</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6459-7470</Identifier><AffiliationInfo><Affiliation>Department of Allergy and Clinical Immunology, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China, 86 189 2886 8259, 86 20 3429 8996.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Public Health Surveill</MedlineTA><NlmUniqueID>101669345</NlmUniqueID><ISSNLinking>2369-2960</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065631" MajorTopicYN="Y">Rhinitis, Allergic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003888" MajorTopicYN="Y">Desensitization, Immunologic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">allergen immunotherapy</Keyword><Keyword MajorTopicYN="N">allergic disease</Keyword><Keyword MajorTopicYN="N">allergic rhinitis</Keyword><Keyword MajorTopicYN="N">antiviral effect</Keyword><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">clinical evidence</Keyword><Keyword MajorTopicYN="N">questionnaire-based survey</Keyword><Keyword MajorTopicYN="N">trajectory</Keyword><Keyword MajorTopicYN="N">viral infection</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>18</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>18</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39412952</ArticleId><ArticleId IdType="pmc">PMC11498206</ArticleId><ArticleId IdType="doi">10.2196/50846</ArticleId><ArticleId IdType="pii">v10i1e50846</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global strategy for asthma management and prevention. Global Initiative for Asthma. 2023.  [02-09-2024]. https://ginasthma.org/2023-gina-main-report/ URL. Accessed.</Citation></Reference><Reference><Citation>Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet. 2011 Dec 17;378(9809):2112–2122. doi: 10.1016/S0140-6736(11)60130-X. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)60130-X</ArticleId><ArticleId IdType="pubmed">21783242</ArticleId></ArticleIdList></Reference><Reference><Citation>Brożek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision. J Allergy Clin Immunol. 2017 Oct;140(4):950–958. doi: 10.1016/j.jaci.2017.03.050. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.03.050</ArticleId><ArticleId IdType="pubmed">28602936</ArticleId></ArticleIdList></Reference><Reference><Citation>Agache I, Lau S, Akdis CA, et al. EAACI guidelines on allergen immunotherapy: house dust mite-driven allergic asthma. Allergy. 2019 May;74(5):855–873. doi: 10.1111/all.13749. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.13749</ArticleId><ArticleId IdType="pubmed">31095767</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts G, Pfaar O, Akdis CA, et al. EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy. 2018 Apr;73(4):765–798. doi: 10.1111/all.13317. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.13317</ArticleId><ArticleId IdType="pubmed">28940458</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhami S, Kakourou A, Asamoah F, et al. Allergen immunotherapy for allergic asthma: a systematic review and meta-analysis. Allergy. 2017 Dec;72(12):1825–1848. doi: 10.1111/all.13208. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.13208</ArticleId><ArticleId IdType="pubmed">28543086</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhami S, Nurmatov U, Arasi S, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis. Allergy. 2017 Nov;72(11):1597–1631. doi: 10.1111/all.13201. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.13201</ArticleId><ArticleId IdType="pubmed">28493631</ArticleId></ArticleIdList></Reference><Reference><Citation>Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol. 2011 Jan;127(1):18–27. doi: 10.1016/j.jaci.2010.11.030. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2010.11.030</ArticleId><ArticleId IdType="pubmed">21211639</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucuksezer UC, Ozdemir C, Cevhertas L, Ogulur I, Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy and allergen tolerance. Allergol Int. 2020 Oct;69(4):549–560. doi: 10.1016/j.alit.2020.08.002. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alit.2020.08.002</ArticleId><ArticleId IdType="pubmed">32900655</ArticleId></ArticleIdList></Reference><Reference><Citation>Romagnani S. Induction of TH1 and TH2 responses: a key role for the “natural” immune response? Immunol Today. 1992 Oct;13(10):379–381. doi: 10.1016/0167-5699(92)90083-J. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0167-5699(92)90083-J</ArticleId><ArticleId IdType="pubmed">1418371</ArticleId></ArticleIdList></Reference><Reference><Citation>Woehlk C, Ramu S, Sverrild A, et al. Allergen immunotherapy enhances airway epithelial antiviral immunity in patients with allergic asthma (VITAL study): a double-blind randomized controlled trial. Am J Respir Crit Care Med. 2023 May 1;207(9):1161–1170. doi: 10.1164/rccm.202209-1708OC. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202209-1708OC</ArticleId><ArticleId IdType="pmc">PMC10161758</ArticleId><ArticleId IdType="pubmed">36701676</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen UI, Xu H, Krause TM, Greenberg R, Dong X, Jiang X. Factors associated with COVID-19 death in the United States: cohort study. JMIR Public Health Surveill. 2022 May 12;8(5):e29343. doi: 10.2196/29343. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/29343</ArticleId><ArticleId IdType="pmc">PMC9132142</ArticleId><ArticleId IdType="pubmed">35377319</ArticleId></ArticleIdList></Reference><Reference><Citation>Qaisieh R, Al-Tamimi M, El-Hammuri N, et al. Clinical, laboratory, and imaging features of COVID-19 in a cohort of patients: cross-sectional comparative study. JMIR Public Health Surveill. 2021 Sep 21;7(9):e28005. doi: 10.2196/28005. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/28005</ArticleId><ArticleId IdType="pmc">PMC8457339</ArticleId><ArticleId IdType="pubmed">34081600</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727–733. doi: 10.1056/NEJMoa2001017. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Laires PA, Dias S, Gama A, et al. The association between chronic disease and serious COVID-19 outcomes and its influence on risk perception: survey study and database analysis. JMIR Public Health Surveill. 2021 Jan 12;7(1):e22794. doi: 10.2196/22794. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/22794</ArticleId><ArticleId IdType="pmc">PMC7806339</ArticleId><ArticleId IdType="pubmed">33433397</ArticleId></ArticleIdList></Reference><Reference><Citation>Gani F, Cottini M, Landi M, et al. Allergic rhinitis and COVID-19: friends or foes? Eur Ann Allergy Clin Immunol. 2022 Mar;54(2):53–59. doi: 10.23822/EurAnnACI.1764-1489.234. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.23822/EurAnnACI.1764-1489.234</ArticleId><ArticleId IdType="pubmed">34503647</ArticleId></ArticleIdList></Reference><Reference><Citation>Radzikowska U, Ding M, Tan G, et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy. 2020 Nov;75(11):2829–2845. doi: 10.1111/all.14429. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14429</ArticleId><ArticleId IdType="pmc">PMC7300910</ArticleId><ArticleId IdType="pubmed">32496587</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghiglioni DG, Cozzi EL, Castagnoli R, et al. Omalizumab may protect allergic patients against COVID-19: a systematic review. World Allergy Organ J. 2023 Feb;16(2):100741. doi: 10.1016/j.waojou.2023.100741. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.waojou.2023.100741</ArticleId><ArticleId IdType="pmc">PMC9826982</ArticleId><ArticleId IdType="pubmed">36644451</ArticleId></ArticleIdList></Reference><Reference><Citation>Larenas-Linnemann DE, Ortega-Martell JA, Blandón-Vijil MV, et al. Coronavirus disease 2019, allergic diseases, and allergen immunotherapy: possible favorable mechanisms of interaction. Allergy Asthma Proc. 2021 May 1;42(3):187–197. doi: 10.2500/aap.2021.42.210013. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.2500/aap.2021.42.210013</ArticleId><ArticleId IdType="pubmed">33980331</ArticleId></ArticleIdList></Reference><Reference><Citation>Juhn YJ. Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease? J Allergy Clin Immunol. 2014 Aug;134(2):247–257. doi: 10.1016/j.jaci.2014.04.024. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2014.04.024</ArticleId><ArticleId IdType="pmc">PMC4122981</ArticleId><ArticleId IdType="pubmed">25087224</ArticleId></ArticleIdList></Reference><Reference><Citation>Gisler A, Eeftens M, de Hoogh K, et al. Pollen exposure is associated with risk of respiratory symptoms during the first year of life. Allergy. 2022 Dec;77(12):3606–3616. doi: 10.1111/all.15284. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15284</ArticleId><ArticleId IdType="pmc">PMC10078730</ArticleId><ArticleId IdType="pubmed">35302662</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Bao Y, Chen J, et al. Chinese guideline on allergen immunotherapy for allergic rhinitis: the 2022 update. Allergy Asthma Immunol Res. 2022 Nov;14(6):604–652. doi: 10.4168/aair.2022.14.6.604. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.4168/aair.2022.14.6.604</ArticleId><ArticleId IdType="pmc">PMC9709690</ArticleId><ArticleId IdType="pubmed">36426395</ArticleId></ArticleIdList></Reference><Reference><Citation>Durham SR, Shamji MH. Allergen immunotherapy: past, present and future. Nat Rev Immunol. 2023 May;23(5):317–328. doi: 10.1038/s41577-022-00786-1. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00786-1</ArticleId><ArticleId IdType="pmc">PMC9575636</ArticleId><ArticleId IdType="pubmed">36253555</ArticleId></ArticleIdList></Reference><Reference><Citation>Woehlk C, von Bülow A, Kriegbaum M, Backer V, Porsbjerg C. Allergic asthma is associated with increased risk of infections requiring antibiotics. Ann Allergy Asthma Immunol. 2018 Feb;120(2):169–176. doi: 10.1016/j.anai.2017.11.015. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2017.11.015</ArticleId><ArticleId IdType="pubmed">29413341</ArticleId></ArticleIdList></Reference><Reference><Citation>Woehlk C, Von Bülow A, Ghanizada M, Søndergaard MB, Hansen S, Porsbjerg C. Allergen immunotherapy effectively reduces the risk of exacerbations and lower respiratory tract infections in both seasonal and perennial allergic asthma: a nationwide epidemiological study. Eur Respir J. 2022 Nov;60(5):2200446. doi: 10.1183/13993003.00446-2022. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00446-2022</ArticleId><ArticleId IdType="pubmed">35618279</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Bona D, Plaia A, Leto-Barone MS, La Piana S, Di Lorenzo G. Efficacy of grass pollen allergen sublingual immunotherapy tablets for seasonal allergic rhinoconjunctivitis: a systematic review and meta-analysis. JAMA Intern Med. 2015 Aug;175(8):1301–1309. doi: 10.1001/jamainternmed.2015.2840. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2015.2840</ArticleId><ArticleId IdType="pubmed">26120825</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogelberg C, Klimek L, Brüggenjürgen B, Jutel M. Real-world evidence for the long-term effect of allergen immunotherapy: current status on database-derived European studies. Allergy. 2022 Dec;77(12):3584–3592. doi: 10.1111/all.15506. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15506</ArticleId><ArticleId IdType="pmc">PMC10087412</ArticleId><ArticleId IdType="pubmed">36074052</ArticleId></ArticleIdList></Reference><Reference><Citation>Calamita Z, Saconato H, Pelá AB, Atallah AN. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method. Allergy. 2006 Oct;61(10):1162–1172. doi: 10.1111/j.1398-9995.2006.01205.x. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1398-9995.2006.01205.x</ArticleId><ArticleId IdType="pubmed">16942563</ArticleId></ArticleIdList></Reference><Reference><Citation>Wongsa C, Phinyo P, Sompornrattanaphan M, Krikeerati T, Lumkul L, Thongngarm T. Efficacy and safety of house dust mite sublingual immunotherapy tablet in allergic asthma: a systematic review of randomized controlled trials. J Allergy Clin Immunol Pract. 2022 May;10(5):1342–1355. doi: 10.1016/j.jaip.2022.01.046. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2022.01.046</ArticleId><ArticleId IdType="pubmed">35181547</ArticleId></ArticleIdList></Reference><Reference><Citation>Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol. 2014 Mar;133(3):621–631. doi: 10.1016/j.jaci.2013.12.1088. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2013.12.1088</ArticleId><ArticleId IdType="pubmed">24581429</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita H, Meyer N, Akdis M, Akdis CA. Mechanisms of immune tolerance to allergens. Chem Immunol Allergy. 2012;96:30–38. doi: 10.1159/000331868. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000331868</ArticleId><ArticleId IdType="pubmed">22433368</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaar O, Fritzsching B, Wolf H, Woehlk C, Wüstenberg E. How does allergen immunotherapy-induced tolerance improve the airway epithelial barrier function: a mechanistical-driven hypothesis. Allergy. 2023 Oct;78(10):2577–2580. doi: 10.1111/all.15835. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15835</ArticleId><ArticleId IdType="pubmed">37545142</ArticleId></ArticleIdList></Reference><Reference><Citation>Xian M, Feng M, Dong Y, Wei N, Su Q, Li J. Changes in CD4+CD25+FoxP3+ regulatory T cells and serum cytokines in sublingual and subcutaneous immunotherapy in allergic rhinitis with or without asthma. Int Arch Allergy Immunol. 2020;181(1):71–80. doi: 10.1159/000503143. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000503143</ArticleId><ArticleId IdType="pmc">PMC6979435</ArticleId><ArticleId IdType="pubmed">31722337</ArticleId></ArticleIdList></Reference><Reference><Citation>Primorac D, Brlek P, Pavelić ES, et al. Importance of cellular immunity and IFN-γ concentration in preventing SARS-CoV-2 infection and reinfection: a cohort study. Viruses. 2023 Mar 20;15(3):792. doi: 10.3390/v15030792. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15030792</ArticleId><ArticleId IdType="pmc">PMC10056614</ArticleId><ArticleId IdType="pubmed">36992500</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanifer ML, Kee C, Cortese M, et al. Critical role of type III interferon in controlling SARS-CoV-2 infection in human intestinal epithelial cells. Cell Rep. 2020 Jul 7;32(1):107863. doi: 10.1016/j.celrep.2020.107863. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.107863</ArticleId><ArticleId IdType="pmc">PMC7303637</ArticleId><ArticleId IdType="pubmed">32610043</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Y, Chen CL, Yu D, Liu Z. Roles of follicular helper and regulatory T cells in allergic diseases and allergen immunotherapy. Allergy. 2021 Feb;76(2):456–470. doi: 10.1111/all.14639. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14639</ArticleId><ArticleId IdType="pubmed">33098663</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Veen W. The role of regulatory B cells in allergen immunotherapy. Curr Opin Allergy Clin Immunol. 2017 Dec;17(6):447–452. doi: 10.1097/ACI.0000000000000400. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACI.0000000000000400</ArticleId><ArticleId IdType="pubmed">28957824</ArticleId></ArticleIdList></Reference><Reference><Citation>Moingeon P, Lombardi V, Baron-Bodo V, Mascarell L. Enhancing allergen-presentation platforms for sublingual immunotherapy. J Allergy Clin Immunol Pract. 2017;5(1):23–31. doi: 10.1016/j.jaip.2016.07.020. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2016.07.020</ArticleId><ArticleId IdType="pubmed">28065340</ArticleId></ArticleIdList></Reference><Reference><Citation>Bousquet J, Humbert M, Gibson PG, et al. Real-world effectiveness of omalizumab in severe allergic asthma: a meta-analysis of observational studies. J Allergy Clin Immunol Pract. 2021 Jul;9(7):2702–2714. doi: 10.1016/j.jaip.2021.01.011. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2021.01.011</ArticleId><ArticleId IdType="pubmed">33486142</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer JA, Wood RA. The use of omalizumab in allergen immunotherapy. Clin Exp Allergy. 2018 Mar;48(3):232–240. doi: 10.1111/cea.13084. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.13084</ArticleId><ArticleId IdType="pubmed">29315922</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer JA, Wood RA. Update on omalizumab in allergen immunotherapy. Curr Opin Allergy Clin Immunol. 2021 Dec 1;21(6):559–568. doi: 10.1097/ACI.0000000000000781. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACI.0000000000000781</ArticleId><ArticleId IdType="pubmed">34419967</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmani AR, Mahdavinezhad F, Moslemi R, et al. Anti-IgE monoclonal antibodies as potential treatment in COVID-19. Immunopharmacol Immunotoxicol. 2021 Jun;43(3):259–264. doi: 10.1080/08923973.2021.1925906. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08923973.2021.1925906</ArticleId><ArticleId IdType="pmc">PMC8146297</ArticleId><ArticleId IdType="pubmed">34018464</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhiba KD, Patel GB, Vu THT, et al. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. J Allergy Clin Immunol. 2020 Aug;146(2):307–314. doi: 10.1016/j.jaci.2020.06.010. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.06.010</ArticleId><ArticleId IdType="pmc">PMC7295471</ArticleId><ArticleId IdType="pubmed">32554082</ArticleId></ArticleIdList></Reference><Reference><Citation>Calmes D, Graff S, Maes N, et al. Asthma and COPD are not risk factors for ICU stay and death in case of SARS-CoV2 infection. J Allergy Clin Immunol Pract. 2021 Jan;9(1):160–169. doi: 10.1016/j.jaip.2020.09.044. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2020.09.044</ArticleId><ArticleId IdType="pmc">PMC7539890</ArticleId><ArticleId IdType="pubmed">33038592</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, Zhang Y, Chen H, Lin J, Zeng J, Xu Z. Inhaled corticosteroids and risk of upper respiratory tract infection in patients with asthma: a meta-analysis. Infection. 2019 Jun;47(3):377–385. doi: 10.1007/s15010-018-1229-y. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-018-1229-y</ArticleId><ArticleId IdType="pubmed">30298471</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson JL, Carroll M, Yang IA, et al. Reduced antiviral interferon production in poorly controlled asthma is associated with neutrophilic inflammation and high-dose inhaled corticosteroids. Chest. 2016 Mar;149(3):704–713. doi: 10.1016/j.chest.2015.12.018. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2015.12.018</ArticleId><ArticleId IdType="pubmed">26836898</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>